Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 6/2012

01-06-2012 | Original Paper

Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia

Authors: Yin-Hua Wang, Zhi-Jian Zou, Ling Liu, Li-Na Zhang, Cheng Fang, Dan-Xia Zhu, Lei Fan, Jian-Yong Li, Wei Xu

Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2012

Login to get access

Abstract

Background

Chronic lymphocytic leukemia (CLL) is heterogeneous with respect to prognosis and clinical outcome. Mutational status of immunoglobulin heavy chain variable region (IGHV) appears to be a particularly strong prognostic marker, but it is difficult to perform in a routine clinical laboratory. ζ-chain-associated protein kinase 70 kDa (ZAP-70) protein detected by flow cytometry is a strong surrogate marker of IGHV mutational status; however, it suffers from the lack of standardization.

Methods

We investigated whether ZAP-70 mRNA expression level can be a prognostic factor in CLL. Real-time quantitative polymerase chain reaction was used to analyze ZAP-70 mRNA expression from 102 CLL patients.

Results

The expression of ZAP-70 mRNA was significantly associated with Binet stage (P < 0.001), lactate dehydrogenase (P = 0.003), ZAP-70 protein (P = 0.018), IGHV mutational status (P = 0.038), and cytogenetic abnormality of del(17p13) or del(11q22.3) (P = 0.037) in CLL patients. According to receiver operating characteristic curve analysis for ZAP-70 mRNA and ZAP-70 protein, positive ZAP-70 mRNA (P = 0.006) was an adverse factor in determining the treatment free survival (TFS). In a multivariate Cox analysis of TFS, ZAP-70 mRNA is not ideal as an independent prognostic factor. However, ZAP-70 mRNA was statistically significant in predicting treatment response.

Conclusion

This study demonstrated the value of determination of ZAP-70 mRNA in providing useful prognostic information in CLL patients. However, ZAP-70 mRNA is not an independent prognostic factor.
Literature
go back to reference Antic D, Mihaljevic B, Cokic V, Fekete MD, Djurasevic TK, Pavlovic S et al (2011) Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling. Leuk Lymphoma 52(7):1394–1397PubMedCrossRef Antic D, Mihaljevic B, Cokic V, Fekete MD, Djurasevic TK, Pavlovic S et al (2011) Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling. Leuk Lymphoma 52(7):1394–1397PubMedCrossRef
go back to reference Best OG, Ibbotson RE, Parker AE, Davis ZA, Orchard JA, Oscier DG (2006) ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis. Cytometry B Clin Cytom 70(4):235–241PubMed Best OG, Ibbotson RE, Parker AE, Davis ZA, Orchard JA, Oscier DG (2006) ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis. Cytometry B Clin Cytom 70(4):235–241PubMed
go back to reference Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198–206PubMedCrossRef Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198–206PubMedCrossRef
go back to reference Catherwood MA, Matthews C, Niblock R, Dobbin E, Morris TC, Alexander HD (2006) ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur J Haemato 76(4):294–298CrossRef Catherwood MA, Matthews C, Niblock R, Dobbin E, Morris TC, Alexander HD (2006) ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur J Haemato 76(4):294–298CrossRef
go back to reference Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87(12):4990–4997PubMed Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87(12):4990–4997PubMed
go back to reference Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348(18):1764–1775PubMedCrossRef Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348(18):1764–1775PubMedCrossRef
go back to reference Gibbs G, Bromidge T, Howe D, Hopkins J, Johnson S (2005) Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. Clin Lab Haematol 27(4):258–266PubMedCrossRef Gibbs G, Bromidge T, Howe D, Hopkins J, Johnson S (2005) Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory. Clin Lab Haematol 27(4):258–266PubMedCrossRef
go back to reference Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW et al (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363(9403):105–111PubMedCrossRef Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW et al (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363(9403):105–111PubMedCrossRef
go back to reference Qiu HX, Xu W, Cao XS, Zhou M, Shen YF, Xu YL et al (2008) Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 49(10):1887–1892PubMedCrossRef Qiu HX, Xu W, Cao XS, Zhou M, Shen YF, Xu YL et al (2008) Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation. Leuk Lymphoma 49(10):1887–1892PubMedCrossRef
go back to reference Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46(2):219–234PubMed Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46(2):219–234PubMed
go back to reference Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351(9):893–901PubMedCrossRef Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG et al (2004) ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med 351(9):893–901PubMedCrossRef
go back to reference Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194(11):1639–1647PubMedCrossRef Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 194(11):1639–1647PubMedCrossRef
go back to reference Shankey TV, Forman M, Scibelli P, Cobb J, Smith CM, Mills R et al (2006) An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia. Cytometry B Clin Cytom 70(4):259–269PubMed Shankey TV, Forman M, Scibelli P, Cobb J, Smith CM, Mills R et al (2006) An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia. Cytometry B Clin Cytom 70(4):259–269PubMed
go back to reference Sheikholeslami MR, Jilani I, Keating M, Uyeji J, Chen K, Kantarjian H et al (2006) Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis. Cytometry B Clin Cytom 70(4):270–275PubMed Sheikholeslami MR, Jilani I, Keating M, Uyeji J, Chen K, Kantarjian H et al (2006) Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: Comparison with IgV(H) mutation analysis. Cytometry B Clin Cytom 70(4):270–275PubMed
go back to reference Stamatopoulos B, Meuleman N, Haibe-Kains B, Duvillier H, Massy M, Martiat P et al (2007) Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem 53(10):1757–1766PubMedCrossRef Stamatopoulos B, Meuleman N, Haibe-Kains B, Duvillier H, Massy M, Martiat P et al (2007) Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem 53(10):1757–1766PubMedCrossRef
go back to reference Tobin G, Rosenquist R (2005) Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia. Med Oncol 22(3):217–228PubMedCrossRef Tobin G, Rosenquist R (2005) Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia. Med Oncol 22(3):217–228PubMedCrossRef
go back to reference Wang YH, Fan L, Xu W, Li JY (2011) Detection methods of ZAP-70 in chronic lymphocytic leukemia. Clin Exp Med (Epub ahead of print) Wang YH, Fan L, Xu W, Li JY (2011) Detection methods of ZAP-70 in chronic lymphocytic leukemia. Clin Exp Med (Epub ahead of print)
go back to reference Xu W, Cao X, Miao KR, Qiao C, Wu YJ, Liu Q et al (2009a) Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Hematol 90(2):205–211PubMedCrossRef Xu W, Cao X, Miao KR, Qiao C, Wu YJ, Liu Q et al (2009a) Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. Int J Hematol 90(2):205–211PubMedCrossRef
go back to reference Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T et al (2009b) CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leuk Res 33(2):237–243PubMedCrossRef Xu W, Li JY, Wu YJ, Yu H, Shen QD, Tian T et al (2009b) CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia. Leuk Res 33(2):237–243PubMedCrossRef
go back to reference Zanotti R, Ambrosetti A, Lestani M, Ghia P, Pattaro C, Remo A et al (2007) ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia 21(1):102–109PubMedCrossRef Zanotti R, Ambrosetti A, Lestani M, Ghia P, Pattaro C, Remo A et al (2007) ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. Leukemia 21(1):102–109PubMedCrossRef
Metadata
Title
Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia
Authors
Yin-Hua Wang
Zhi-Jian Zou
Ling Liu
Li-Na Zhang
Cheng Fang
Dan-Xia Zhu
Lei Fan
Jian-Yong Li
Wei Xu
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 6/2012
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-012-1177-3

Other articles of this Issue 6/2012

Journal of Cancer Research and Clinical Oncology 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.